Searched for
API ACQUISITION
RPG Life Sciences subsidiary acquires Raghava Life Sciences' API biz for Rs 135 crRPG Active Pharma is acquiring Raghava Life Sciences' API and intermediates business. This strategic move aims to strengthen its integrated...- Gupshup launches voice AI platform for businessesConversational messaging software provider Gupshup has launched a self-serve voice AI platform that enables businesses to build and run AI ...
- Sun Pharma to extend MFN pricing to US state Medicaid programmesSun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...
- Stocks in news: HDFC Bank, Ola Electric Mobility, NBCC and Knowledge Realty TrustIndian equity markets closed higher on Friday, ending a losing streak with IT stock gains. HDFC Bank's CEO will not seek reappointment, whi...
- From 100,000 calls a month to 5 million a day: Inside Vobiz’s AI telephony betFounded by Suman Gandham and Vikash Srivastava, Vobiz is betting that the rise of AI voice agents will require a telecom layer built for ma...
- Pharmeasy-parent’s loss narrows in Q1, revenue up 10%API Holdings, parent of PharmEasy and Thyrocare, narrowed its Q1 FY27 loss to Rs 29.6 crore from Rs 145.4 crore a year earlier, while reven...
- Shiprocket lifts off: The fire that fuels the new logistics engineShiprocket’s strong stock market debut reflects surging investor confidence in India’s tech-driven e-commerce infrastructure. As rapid D2C ...
- Pharmeasy founder says failure to deleverage was key reason for debt sagaSiddharth Shah’s comments came a day after API Holdings repaid Rs 1,050 crore of debt, becoming debt-free after years of pressure on its ba...
- Pharmeasy parent clears Rs 1,050 crore debt, frees Thyrocare stake from pledgeThe debt repayment marks the latest step in API Holdings’ efforts to clean up its balance sheet after a difficult period struggling to rais...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsLooking at what happens in the short term is important, as it does have an impact on stock prices. But also always keep an eye on the macro...
- Gland Pharma appoints Dr Reddy’s senior executive Deepak Sapra as CEOGland Pharma has appointed Deepak Sapra as its new chief executive officer, with his tenure set to begin on November 16, 2026, subject to h...
- Sun Pharma Q1 Results: Profit rises 27% YoY to Rs 2,895 crore; revenue climbs 10.5%Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, dr...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThe price of crude oil is down again despite the escalating tensions in the Gulf region. That augurs well for markets. This does not mean t...
- Stocks in news: Infosys, Cipla, Meesho, Suzlon Energy, IndiGo, NTPCMarkets extended their losing streak for a fourth consecutive session. Infosys reported a 12% year-on-year profit growth in its first quart...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%It may take a while for clarity to emerge in the Gulf region. In the meantime, focus on fundamentals and how they pan out in the next coupl...
- AI is reshaping hiring, making evidence-based verification more critical: Millow's Karan BhattyAI is revolutionising Indian hiring by enhancing candidate preparation and employer verification processes. Companies now prioritise eviden...
- Setu chief business officer Anand Raisinghani steps downAnand Raisinghani has resigned from his role at Pine Labs-owned Setu, an API infrastructure company. He is stepping down to pursue new care...
- Warburg Pincus buys Mumbai’s pharma company Integrace in Rs 1,200 crore dealIn a landmark transaction, Warburg Pincus, a prominent US private equity firm, has purchased Integrace Private Limited for ₹1,200 crore. Wi...
- Global creditors drag Udaan's parent to bankruptcy court in Singapore after $170-million bond defaultInsolvency petition filed this week, A&M appointed as liquidator of B2B commerce company. Ten year old co has seen valuations crash 70% as ...
- India's pharma supply chain remains 65 per cent dependent on China for critical inputs: NITI AayogIndia's pharmaceutical sector, despite being the "pharmacy of the world," faces significant reliance on China for raw materials, with nearl...
Load More
